Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Dolutegravir

An antiretroviral integrase inhibitor, blocking the enzyme HIV uses to insert its genetic material into the host cell's DNA; approved in the United States in 2013 and in Europe in 2014. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?In 2019 the World Health Organization recommended it as both a first-line and a second-line treatment for all people living with HIV.

DolutegravirGo to the active ingredient →
DolutegravirActive ingredientDolutegravirCat. No. P-D166-001CAS 1051375-16-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.